Cory Robinson is an Associate Professor in the Department of Microbiology, Immunology, & Cell Biology at West Virginia University School of Medicine. He received his Bachelor’s degree from Bowling Green State University, and a Ph.D. from the Miami University.
Dr. Robinson’s research has always been at the interface of host and pathogen interactions. In his first postdoctoral fellowship with Alison O’Brien at the Uniformed Service University, he studied the influence of Shiga toxin on colonization of the mouse intestine and human epithelial cells by Enterohemorrhagic E. coli. He then pursued additional postdoctoral work with Gerard Nau at the University of Pittsburgh School of medicine studying the influence of interleukin (IL)-27 on human macrophage control of Mycobacterium tuberculosis.
Dr. Robinson received a K99 Pathway to Independence Award from the NIH in 2009 that allowed him to establish an independent laboratory that he has continued to fund through the present with NIH and other extramural mechanisms. His research program focuses on the involvement of IL-27 in host immune responses to bacterial infections and vaccination during the neonatal period. This involves neonatal mouse models of infection and vaccination, along with complementary in vitro studies with primary immune cells isolated from neonatal blood.